Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Generate Biomedicines, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GENB
Nasdaq
2836
generatebiomedicines.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Generate Biomedicines, Inc.
Generate Biomedicines (GENB) Stock Looks Fully Priced On Its 17% Jump
- Oct 31st, 2026 12:18 am
Anthropic Announced New Achievements in Drug Research and Lab Work. An Expert Says AI is 'Changing the Medical Field.'
- Oct 29th, 2026 8:43 am
Generate Biomedicines to Participate in November Investor Conferences
- Oct 22nd, 2026 5:00 am
Zealand Pharma pens $1.2bn AI obesity drug discovery pact with Generate
- Oct 14th, 2026 10:17 am
Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market
- Oct 14th, 2026 9:30 am
Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
- Oct 13th, 2026 2:30 pm
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
- Oct 13th, 2026 2:30 pm
Prologue Medicines Appoints Stephen Harrison, Ph.D., as Chief Scientific Officer
- Oct 13th, 2026 8:00 am
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
- Oct 1st, 2026 5:00 am
AI Could Eventually Crack Cancer and Drug Discovery, Says Arm CEO — But This Is What’s Holding It Back
- Sep 8th, 2026 8:36 am
Generate Biomedicines Inc. to Participate in September Investor Conferences
- Sep 8th, 2026 5:09 am
How Nvidia’s Investment Juggernaut Can Jump from Big to Enormous
- Sep 7th, 2026 8:07 am
Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines
- Aug 28th, 2026 5:59 am
EXCLUSIVE: Nvidia GPUs Are Essential—But They Won't Decide Who Wins AI Drug Discovery, Generate CTO Says
- Aug 27th, 2026 5:31 pm
Cathie Wood Sends a $20 Million Signal on Broadcom Stock
- Aug 27th, 2026 1:18 pm
Generate Biomedicines (GENB) Stock Looks Pricey On Book Value Yet Strong On Returns
- Aug 26th, 2026 4:16 pm
Generate Biomedicines stock jumps as post-IPO lock-up set to expire
- Aug 25th, 2026 9:10 am
Nvidia Holds More Than 122 Million Shares of SPCX Stock After Q2. Barchart Data Shows It’s Making a High-Upside Bet.
- Aug 18th, 2026 12:56 pm
Two Positions Make Up 80% of Nvidia's $63.4 Billion Portfolio
- Aug 17th, 2026 10:12 am
Scroll